Form 4: Exelixis EVP and CFO Christopher J. Senner Reports Changes in Beneficial Ownership
SEC Form 4
Christopher J. Senner, EVP and CFO of Exelixis, Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On May 15, 2024, Christopher J. Senner, the EVP and CFO of Exelixis, Inc., had shares of common stock withheld by the company to cover tax obligations.
- A total of 8,621 shares were withheld at a price of $20.99 related to restricted stock units awarded on March 4, 2021.
- Additionally, 10,211 shares were withheld at $20.99 related to restricted stock units awarded on March 4, 2022.
- Furthermore, 11,478 shares were withheld at $20.99 related to restricted stock units awarded on April 3, 2023.
- Following these transactions, Senner directly owns 721,680 shares and indirectly owns 2,723 shares through a 401(k) plan.
Sentiment
Score: 5
Explanation: This is a neutral filing related to routine tax obligations. It doesn't convey any particularly positive or negative sentiment regarding the company's performance or outlook.
Industry Context
This filing is a routine disclosure related to executive compensation and tax obligations, common among publicly traded companies. It doesn't necessarily indicate a strategic shift or significant event for Exelixis.
Comparison to Industry Standards
- Executive compensation practices, including the use of restricted stock units and tax withholding, are standard across the biotechnology industry.
- Companies like Amgen, Gilead Sciences, and Biogen also utilize similar equity-based compensation strategies for their executives.
- The amount of shares withheld for taxes is dependent on the executive's compensation package and the company's equity grant policies, which are generally benchmarked against peer companies.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it relates to tax obligations from executive compensation.
- Employees holding restricted stock units may experience similar tax withholding upon vesting.
Key Dates
| Date | Description |
|---|---|
| 03/04/2021 | Date of restricted stock units awarded related to tax withholding. |
| 03/04/2022 | Date of restricted stock units awarded related to tax withholding. |
| 04/03/2023 | Date of restricted stock units awarded related to tax withholding. |
| 05/14/2024 | Date of plan statement for Exelixis, Inc. 401(k) Plan. |
| 05/15/2024 | Date of transaction: shares withheld for tax obligations. |
| 05/17/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.